BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11798580)

  • 1. [Hypermethylation of the calcitonin gene as molecular genetic marker in detecting minimal residual disease of leukemia].
    Tang Y; Deng C; Du Q; Li G; Zeng Z; Zhang J; Miu S
    Zhonghua Nei Ke Za Zhi; 2001 Apr; 40(4):226-8. PubMed ID: 11798580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia].
    Xie XH; Chen ZZ; Zhang XM; Huang MQ
    Ai Zheng; 2003 Jun; 22(6):616-9. PubMed ID: 12948412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on hypermethylation of the calcitonin gene in malignant hematological disorders].
    Tang Y; Deng C; Du Q; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):86-8. PubMed ID: 12733364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypermethylation of the human calcitonin gene as a molecular marker in acute lymphoid leukemia].
    Marinich DV; Uss AL; Smirnova LA; Vorob'ev IA; Holmes J; Sulimova GE; Shevchuk TV; Bur'ianov IaI
    Vopr Med Khim; 2001; 47(5):537-46. PubMed ID: 11766265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
    Tan B; Cao P; Qi Z
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):371-3. PubMed ID: 12080652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the calcitonin gene and leukemia.
    Baruchel A; Sigaux F
    Nouv Rev Fr Hematol (1978); 1991; 33(6):551-3. PubMed ID: 1818314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission.
    Thomas X; Teillon MH; Belhabri A; Rimokh R; Fiere D; Magaud JP; Archimbaud E
    Hematol Cell Ther; 1999 Feb; 41(1):19-26. PubMed ID: 10193642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
    Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis.
    Maeda Y; Horiuchi F; Morita S; Matsuda M; Shirakawa C; Masaki H; Koyama A; Hamazaki H; Fujimoto T; Irimajiri K
    Exp Hematol; 1994 Aug; 22(9):881-7. PubMed ID: 8062887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
    Xu D; Hong W; Wang S
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome.
    Chen ZX; Kaeda J; Saunders S; Goldman JM
    Chin Med J (Engl); 2004 Jul; 117(7):968-71. PubMed ID: 15265366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
    Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
    Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.